Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions